Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
53
ARGX Quote, Financials, Valuation and Earnings
Last price:
$622.99
Seasonality move
:
1.41%
Day range:
$619.60 - $634.40
52-week range:
$349.86 - $644.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
20.45x
P/B ratio:
8.75x
Volume:
269.2K
Avg. volume:
308.7K
1-year change:
84.07%
Market cap:
$37.3B
Revenue:
$1.2B
EPS (TTM):
-$0.85
Analysts' Opinion
-
Consensus Ratingargenx SE has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $655.15, argenx SE has an estimated upside of 5.02% from its current price of $623.82.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $521.40 representing 16.42% downside risk from its current price of $623.82.
Fair Value
-
According to the consensus of 15 analysts, argenx SE has 5.02% upside to fair value with a price target of $655.15 per share.
ARGX vs. S&P 500
-
Over the past 5 trading days, argenx SE has overperformed the S&P 500 by 4.82% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
argenx SE does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
argenx SE has grown year-over-year revenues for 9 quarters straight. In the most recent quarter argenx SE reported revenues of $573.2M.
Earnings Growth
-
argenx SE has grown year-over-year earnings for 0 quarters straight. In the most recent quarter argenx SE reported earnings per share of $1.39.
Enterprise value:
34.2B
EV / Invested capital:
--
Price / LTM sales:
20.45x
EV / EBIT:
--
EV / Revenue:
18.40x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-26.80x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.7B
Return On Assets:
-4.89%
Net Income Margin (TTM):
-2.17%
Return On Equity:
-6.01%
Return On Invested Capital:
-5.47%
Operating Margin:
2.82%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $262.6M | $993.6M | $1.9B | $329.8M | $573.2M | |
| Gross Profit | $246M | $902.5M | $1.7B | $293.8M | $514.2M | |
| Operating Income | -$848M | -$401.8M | -$256.2M | -$79.8M | $16.2M | |
| EBITDA | -$932.4M | -$284.7M | -$60.5M | -$83M | $88.7M | |
| Diluted EPS | -$17.06 | -$4.16 | -$0.85 | -$1.25 | $1.39 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -$285.4M | -$124.7M | |
| Cash From Investing | -- | -- | -- | $527M | -$513.8M | |
| Cash From Financing | -- | -- | -- | $62.3M | $40.1M | |
| Free Cash Flow | -$656.9M | -$910.6M | -$1.3B | -$285.9M | -$147M | |
ARGX
Sector
Market Cap
$37.3B
$44.6M
Price % of 52-Week High
96.72%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
84.07%
-29.09%
Beta (5-Year)
0.589
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$620.11
200-day SMA
Buy
Level
$479.04
Bollinger Bands (100)
Buy
Level
519.29 - 596.59
Chaikin Money Flow
Buy
Level
2.6M
20-day SMA
Buy
Level
$616.49
Relative Strength Index (RSI14)
Buy
Level
58.04
ADX Line
Sell
Level
8.95
Williams %R
Neutral
Level
-49.7237
50-day SMA
Buy
Level
$589.23
MACD (12, 26)
Buy
Level
10.32
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
15.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (30.6524)
Buy
CA Score
(Annual)
Level (1.1411)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.8158)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
Stock Forecast FAQ
In the current month, ARGX has received 13 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ARGX average analyst price target in the past 3 months is $655.15.
-
Where Will argenx SE Stock Be In 1 Year?
According to analysts, the consensus estimate is that argenx SE share price will rise to $655.15 per share over the next 12 months.
-
What Do Analysts Say About argenx SE?
Analysts are divided on their view about argenx SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that argenx SE is a Sell and believe this share price will drop from its current level to $521.40.
-
What Is argenx SE's Price Target?
The price target for argenx SE over the next 1-year time period is forecast to be $655.15 according to 15 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ARGX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for argenx SE is a Buy. 13 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ARGX?
You can purchase shares of argenx SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase argenx SE shares.
-
What Is The argenx SE Share Price Today?
argenx SE was last trading at $622.99 per share. This represents the most recent stock quote for argenx SE. Yesterday, argenx SE closed at $623.82 per share.
-
How To Buy argenx SE Stock Online?
In order to purchase argenx SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
